FIELD: medicine.
SUBSTANCE: ovarian tumour tissue is examined for a portion of the synthesis cycling-state cell; if the derived value is less than 15.9%, a favourable outcome is predicted, while at the derived value being more than 15.9%, an unfavourable outcome is predicted. The invention can be used more than once in clinics for women and special oncological hospitals for the purpose of predicting recurrent ovarian carcinoma according to the tumour tissue DNA-cytometry findings.
EFFECT: higher prediction accuracy.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE RELAPSE OF SEROUS OVARIAN CANCER | 2005 |
|
RU2290078C1 |
| METHOD FOR PREDICTING EARLY RECURRENCE OF CLEAR CELL CARCINOMA OF THE UTERINE BODY | 2022 |
|
RU2784775C1 |
| METHOD FOR PREDICTION OF RISK OF TUMOUR PROGRESSION IN PATIENTS WITH OVARIAN CANCER | 2023 |
|
RU2816339C1 |
| METHOD OF ESTIMATION OF RISK OF RECURRENCY OF OVARIAN CANCER | 2017 |
|
RU2658047C1 |
| METHOD FOR PREDICTION OF PROBABILITY OF POSSIBLE EXECUTION OF OPTIMUM CYTOREDUCTIVE OPERATION IN PATIENTS WITH DISSEMINATED FORMS OF OVARIAN CANCER | 2017 |
|
RU2637399C1 |
| METHOD FOR PREDICTING SURVIVAL PERIOD IN SEROUS OVARY CARCINOMA PATIENTS OF REPRODUCTIVE AGE | 2005 |
|
RU2290640C1 |
| METHOD OF DETERMINING DURATION OF RECURRENCE-FREE INTERVAL IN SEROUS OVARIAN CANCER | 2015 |
|
RU2613302C1 |
| METHOD FOR PREDICTING SURVIVAL RATE IN PATIENTS WITH ENDOMETRIOID CANCER OF UTERINE BODY | 2006 |
|
RU2299690C1 |
| METHOD FOR PREDICTING SEROUS OVARIAN CARCINOMA PATIENTS SURVIVAL PERIOD IN CLIMACTERIC PERIOD AND POSTMENOPAUSE | 2005 |
|
RU2291435C1 |
| METHOD FOR PREDICTION OF THE PATHOLOGICAL PROCESS IN UTERINE BODY CANCER | 2019 |
|
RU2712307C1 |
